Novartis AG (NYSE:NVS)
| 88.98 BATS BZX Real-Time Price As of 10:21am ET |  +0.58 / +0.66%Today’s Change | 77.04 Today|||52-Week Range 98.52 | -5.77% Year-to-Date |
Latest NVS News | Press Releases
Today’s Trading
| Previous close | 88.40 |
| Today’s open | 89.11 |
| Day’s range | 88.97 - 89.18 |
| Volume | 317,061 |
| Average volume (3 months) | 1,988,655 |
| Market cap | $197.7B |
Data as of 10:21am ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | +15.91% |
| Earnings growth (this year) | +9.43% |
| Earnings growth (next 5 years) | +8.41% |
| Revenue growth (last year) | +2.95% |
| P/E ratio | 25.6 |
| Price/Sales | 4.43 |
| Price/Book | 3.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.15 | +0.19% |
| ABBVAbbVie | +0.20 | +0.17% |
| LLYEli Lilly and Co | +1.67 | +0.86% |
| PFEPfizer | +0.01 | +0.02% |
Data as of 10:22am ET, 05/14/2021
Financials
| Next reporting date | July 21, 2021 |
| EPS forecast (this quarter) | $1.54 |
| Annual revenue (last year) | $48.9B |
| Annual profit (last year) | $8.1B |
| Net profit margin | 16.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
